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Background. A growing tumor in the body can be considered a complex ecological and evolutionary system. A new eco-
evolutionary hypothesis (the ‘‘Growth Rate Hypothesis’’, GRH) proposes that tumors have elevated phosphorus (P) demands due
to increased allocation to P-rich nucleic acids, especially ribosomal RNA, to meet the protein synthesis demands of accelerated
proliferation. Methodology/Principal Findings. We determined the elemental (C, N, P) and nucleic acid contents of paired
malignant and normal tissues from colon, lung, liver, or kidney for 121 patients. Consistent with the GRH, lung and colon tumors
were significantly higher (by approximately two-fold) in P content (fraction of dry weight) and RNA content and lower in nitrogen
(N):P ratio than paired normal tissue, and P in RNA contributed a significantly larger fraction of total biomass P in malignant
relative to normal tissues. Furthermore, patient-specific differences for %P between malignant and normal tissues were positively
correlated with such differences for %RNA, both for the overall data and within three of the four organ sites. However, significant
differences in %P and %RNA between malignant and normal tissues were not seen in liver and kidney and, overall, RNA
contributed only ,11% of total tissue P content. Conclusions/Significance. Data for lung and colon tumors provide support for
the GRH in human cancer. The two-fold amplification of P content in colon and lung tumors may set the stage for potential P-
limitation oftheir proliferation, assuchdifferences often dofor rapidly growingbiota inecosystems.However, data forkidney and
liver do not support the GRH. To account for these conflicting observations, we suggest that local environments in some organs
select for neoplastic cells bearing mutations increasing cell division rate (‘‘r-selected,’’ as in colon and lung) while conditions
elsewhere may select for reduced mortality rate (‘‘K-selected,’’ as in liver and kidney).
Citation: Elser JJ, Kyle MM, Smith MS, Nagy JD (2007) Biological Stoichiometry in Human Cancer. PLoS ONE 2(10): e1028. doi:10.1371/
journal.pone.0001028
INTRODUCTION
Despite a greatly expanded knowledge base, post-occurrence
cancer survival rates have shown only modest improvements in
recent decades [1]. Thus, new approaches are needed that can
integrate the diverse body of knowledge in this field to yield a better
understanding of cancer and improve available therapies. One
increasingly important emphasis in cancer biology is to consider
the neoplasm and host as a complex ecological system in which
genetically heterogeneous tumor populations undergo evolution-
ary change [2],[3]. This emphasis becomes increasingly compel-
ling in light of findings of ‘‘cryptic cancer’’, in which modern
molecular screening indicates the widespread presence of cells
containing known oncogene-specific mutations in otherwise
healthy tissue [4]. While such ‘‘precancers’’ may still lack key
mutations for complete oncogenic transformation, such observa-
tions also suggest that important aspects of a genetically divergent
cell’s environment may be critical in its eventual development into
a physiologically significant tumor. However, eco-evolutionary
approaches are not yet widespread and few attempts have been
made to operationalize the ecological mechanisms at play in
a tumor-host ecosystem.
Ecological stoichiometry is the study of the balance of energy
and multiple chemical elements in ecological interactions [5].
More recently, this approach has been extended to a broader set of
evolutionary and functional questions beyond ecology; this
extended theory is biological stoichiometry [6]. In this context, it
has recently been proposed that tumor cells present an example of
a stoichiometric syndrome in which there are close positive
associations among growth rate, biomass RNA content (fraction of
dry mass), and biomass phosphorus (P) content [7]. These
associations occur because rapidly proliferating cells generally
increase their allocation to P-rich ribosomal RNA to meet the
elevated protein synthesis demands of high growth rate. This
‘‘Growth Rate Hypothesis’’ (GRH hereafter) has received
considerable support in recent studies involving diverse biota
ranging from fruit flies to bacteria [8]. One corollary of this
hypothesis is that, all else being equal, P-rich biota should be more
frequently limited by environmental or dietary P supply [8]. Thus,
the GRH predicts that tumors may be susceptible to in vivo P-
limitation of growth [7]. We tested the GRH in the context of
cancer biology by evaluating the nitrogen (N), P, and nucleic acid
(RNA, DNA) contents of paired malignant and adjacent normal
tissue biopsies originating from colon, liver, kidney, and lung.
METHODS
Sample Analyses and Database
Biopsy samples were obtained via the Cooperative Human Tissue
Network (CHTN) of the National Cancer Institute. Samples were
obtained nearly exclusively from primary tumors originating in
four organs (liver, kidney, colon/rectum, or lung). According to
standard CHTN procedures, samples of tumor and of healthy
adjacent tissues were obtained, with a portion examined by
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in liquid nitrogen and held at 270uC until shipment on dry ice to
ASU where they were held at 280uC until further processing. For
nucleic acid analysis, sub-samples from each biopsy sample were
fractured on dry ice and 50–100 mg samples were immediately
homogenized with 1 ml Trizol (Invitrogen
TM). Following estab-
lished extraction procedures [9], after incubation for 10 min at
room temperature one-fifth volume of chloroform was added and
mixed, after which the phases were separated by centrifugation at
12,000 g for 15 min at 4uC. The organic phase was re-extracted,
and the pooled aqueous phase was precipitated with isopropanol
and centrifuged at 12,000 g for 10 min at 4uC. The pellet was
then washed with cold 75% ethanol and re-centrifuged, as per the
manufacturer’s protocol. The final RNA product was treated with
RNAse-free DNAse using DNA-free reagents (Ambion). DNA was
extracted from frozen sub-samples using the QIAamp DNA
minikit (QIAGEN
TM). Nucleic acid concentrations of extracts
were then quantified using a NanoDropH ND-1000 spectropho-
tometer. Since samples for nucleic acid analysis could not be dried
for comparison with elemental analyses, for each organ we
developed an empirical factor to convert fresh-frozen weight to dry
weight. To assess possible RNA degradation during sample
handling, all extracts were also subjected to a quantitative real-
time PCR assay for amplification of the 177 bp mRNA of
the hypoxanthine guanine phosphoribosyltransferase 1 (HPRT)
housekeeping gene [10]. Samples indicating possible RNA
degradation were excluded from analysis. Sub-samples for
elemental analysis were dried and weighed and then analyzed
for P by colorimetry [11] or for carbon (C) and N (via
a PerkinElmer model 2400 Elemental Analyzer). All results were
then expressed as a percentage of dry weight. To estimate the
percentage of total biomass P contributed by RNA, RNA content
was multiplied by 0.086, the mass fraction of RNA contributed by
P [5], and then compared with total P content.
Statistical Analysis
All comparative measures, i.e., %P, %N, N:P ratio, %RNA,
%DNA and % of P contributed by RNA, were handled similarly.
For each tissue of origin (colon/rectum, kidney, liver and lung),
data were analyzed directly and after being summarized in pair-
wise fashion for each patient as a ratio of malignant tissue to
normal. Ratios for percentage of P contributed by RNA were log-
transformed. Outliers, defined as any measurement falling more
than 1.5 inner-quartile ranges beyond the nearest inner quartile
for a specific tissue, were removed before further analyses. No
more than one or two data points were removed as clear outliers in
any given analysis. Deviations from normality were probed with
D’Agostino’s test for skewness and Anscombe-Glynn tests for
kurtosis. We tested homogeneity of variance assumptions and also
compared variances of normal and malignanttissues for all measures
using the Fligner-Killeen test for homogeneity of variance, both for
the overall data set and for each organ site. In every case but two,
Fligner-Killeen agreed with an analogous Bartlett test. In both
exceptions, the Bartlett algorithmwas obviouslyaffected byskewness
in the data. If normality and variance assumptions were met,
absolute data were analyzed by two-way analysis of variance
(ANOVA) with organ (liver, kidney, colon, lung) and tissue type
(normal, malignant) as independent variables. The pair-wise
malignant/normal ratios were evaluated for significant differences
between malignant and normal tissues for the four organ sites by
using one-sample t-tests on the null hypothesis that all (four)
parametric ratios equaled unity. If assumptions of normality were
not met, we performed analogous one-sample Wilcoxon tests on the
analogous null. Attained significance for these multiple comparisons
was adjustedusing Holm’sprocedurefor eachcomparative measure.
In addition, to evaluate among-site differences in chemical
composition among healthy tissues, we also performed Kruskal-
Wallis tests for each parameter. This test is robust against violations
of the assumptions of ANOVA. We also report Pearson’s product
moment correlation coefficient between total P and RNA content.
All statistical calculations were performed using R Statistical
Software, version 2.1.1.
RESULTS AND DISCUSSION
Analysis of variance indicated that the four organs sampled
differed significantly overall in nearly all measures of elemental
and biochemical composition (Table 1). P-content (percent of dry
Table 1. Results of two-way Analysis of Variance (ANOVA)
evaluating the statistical significance of differences in
elemental and biochemical parameters in biopsy samples as
a function of site (kidney, liver, colon, lung) and status
(normal, malignant); the significance of the site-by-status
interaction was also evaluated.
......................................................................
Source d.f. F p, K-W p,
%P
site 3 2.47 0.06 10
26
status 1 34.1 10
27




site 3 2.47 0.014 0.01
status 1 34.1 0.15
site6status 3 10.9 0.0027
residuals 202
N:P
site 3 3.60 0.014 10
26
status 1 9.50 0.002




site 3 13.37 10
27 10
27
status 1 25.7 10
26




site 3 8.55 10
24 10
24
status 1 11.0 0.002




site 3 7.36 10
24 10
24
status 1 5.85 0.016
site6status 3 1.42 0.24
residuals 203
The final column reports the p value from the Kruskal-Wallis test for
homogeneity of medians among normal tissues according to site (organ). This





























































































































































PLoS ONE | www.plosone.org 2 October 2007 | Issue 10 | e1028mass) was relatively high in normal samples (Figure 1A) from both
kidney and liver (,0.75–0.85%) compared to samples from colon
and lung (,0.55%), although this overall difference was only
marginally significant (p=0.06). In contrast, tissue N-content was
significantly different among organs (p,0.015), primarily due to
a somewhat decreased %N in liver (Figure 1C). N:P ratios in
normal tissue inversely reflected those for P content (Figure 2A)
and differed significantly among organs (p,0.015), reflecting
lower N:P in kidney and especially liver. Among-organ differences
in both RNA content (percent of dry mass) and DNA content for
normal tissues (Figure 3A and 3C) were highly significant
(p,10
24), being higher in liver (,1.3% and 0.75% respectively)
relative to normal samples from kidney, colon, and lung (0.5–0.7%
and 0.25–0.35%, respectively). Finally, among-organ differences in
%P in RNA for normal tissues also differed significantly (p,10
24).
The percentage of total P contributed by P in RNA for normal
tissues (Figure 2C) ranged from 7% (lung) to 14% (liver). As
expected from the relatively uniform %C of major biomolecules
[5], %C did not differ very much among organs, although the
among-site differences were statistically significant (p,0.01).
Median %C values for the four organs were: 48.9% (lung), 51.2
(colon), 51.2 (kidney), 51.4 (liver).
Next we consider differences between malignant and normal
tissues. There was generally greater variance in %P and %RNA in
malignant tissues relative to normal tissues (see Figures 4 and 5),
both for the overall data set and for each organ site considered
separately (p,0.04 from Fligner-Killeen test, except for RNA
content in liver where p=0.80). These differences likely reflect the
fact that malignant tissue samples contain variable mixtures of
both normal and transformed cells while normal samples contain
only normal cells. Consistent with the GRH, malignant tissues
differed significantly from normal tissues in all parameters
analyzed {except for %N (p=0.15 in two-way ANOVA) and
%C (p=0.89); note that these are not predicted to differ under the
GRH}. However, these differences depended on the organ from
which the tumor samples were obtained (Figures 1–5, Table 1).
These differences are more precisely assessed by considering the
patient-specific data for each parameter in paired malignant and
normal tissues (right hand panels in Figures 1–3 and scatter-plots
for paired %P and %RNA data in Figures 4 and 5). In colon and
lung, tumor P content was approximately double that in normal
tissue (p,10
23, based on one-sample t-test; Figure 1B), while
kidney and liver tumors did not differ (p.0.5) in P content from
normal tissue. Since N-content was similar in malignant and
normal tissues (except for liver, where N-content was somewhat
higher in malignant samples; Figure 1D), N:P ratios (Figure 2B)
were also significantly lower in colon and lung tumor samples
(p,0.01) but did not differ in kidney and liver (p.0.08).
Consistent with the GRH, there was a broad similarity between
the patterns observed for P content and for RNA content
(compare Figure 3B with Figure 1B and Figure 5 with Figure 4),
as RNA concentrations in malignant tissue were ,2.5-fold higher
than in normal tissues for colon and lung (p,10
24) but not for
kidney and liver (p.0.8). This pattern also held for DNA
concentrations (p,0.02 for colon, lung, and kidney but p.0.4
for liver, Figure 3D), likely reflecting increased ploidy levels that
are often observed in advanced tumors [12]. Finally, the
percentage of P contributed by RNA was ,1.5-times higher in
malignant relative to normal tissues in all of the organs (Figure 2D),
but this was significant only for colon and lung cancer (p,0.003;
p.0.3 for liver and kidney). We also performed paired ANOVA
for each parameter and obtained results highly consistent with the
one-sample t-tests. Additional support for the GRH comes from
comparison of patient-specific ‘‘residuals’’ from %P and %RNA
Figure 1. Absolute and relative values for elemental composition in normal and malignant tissues of liver, kidney, colon, and lung. A. and B. P
content. C. and D. N content. The number of observations contributing to each mean is given by the number associated with each bar or point. Data
in the right hand panels are expressed as the mean of the patient-specific ratios of malignant relative to normal tissue values (m/n ratio) for each
parameter. The horizontal line shows an m/n ratio of one, indicating no difference between malignant and normal tissues. Error bars indicate6one
standard error. Asterisks next to each symbol in the right hand panels indicate the results of the organ-specific t-test examining whether the m/n ratio
differs from one for that organ (***=p,0.0001; **=0.0001,p,0.001; *=0.001,p,0.05; no asterisk=non-significant).
doi:10.1371/journal.pone.0001028.g001
Tumor Stoichiometry
PLoS ONE | www.plosone.org 3 October 2007 | Issue 10 | e1028data depicted in Figures 4 and 5. Finally, we determined the
patient-specific differences between tumor and normal %P and
between tumor and normal %RNA and evaluated, for the overall
data set and within each organ site, the degree to which patients
having large increases in %P in tumor tissue relative to normal
tissue also had correspondingly large deviations in %RNA. There
were significant positive correlations between these patient-specific
differences both for the overall data set (p,10
28, r
2=0.28) and for
three of the four organ sites (p,0.05, r
2=0.09 to 0.36; for colon,
p=0.18, r
2=0.02). This provides evidence that the GRH holds
not only at the aggregate scale of the overall averages but also at
the scale of individual patients.
While the findings just described are broadly consistent with the
GRH, in our samples RNA contributed only ,10% of total P, in
Figure 3. Absolute and relative (malignant/normal) values of biochemical parameters in normal and malignant tissues of liver, kidney, colon,
and lung. A. and B. RNA content. C. and D. DNA content. Data are expressed as in Figure 1.
doi:10.1371/journal.pone.0001028.g003
Figure 2. Absolute and relative (malignant/normal) values for N:P ratio and percentage of P in RNA for normal and malignant tissues of liver,
kidney, colon, and lung. A. Absolute values and B. relative values for N:P ratio. C. Absolute values and D. relative values for %P in RNA. Data are
expressed as in Figure 1.
doi:10.1371/journal.pone.0001028.g002
Tumor Stoichiometry
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and insects [8]. The relatively low contribution of RNA to P in our
samples may reflect methodological effects or real differences
between these human tissues and the invertebrate and bacterial
samples analyzed previously. For example, RNA degradation
prior to sample freezing may result in an underestimate of the
contribution of RNA to overall P. However, since we used analysis
of the HPRT housekeeping gene to remove RNA samples that
may have been significantly degraded, this is unlikely to have
contributed significantly to our findings. Another possibility is that
RNA extraction efficiency from our relatively large and biochemi-
cally heterogeneous tumor and normal samples was low compared
to RNA recovery from small invertebrates and bacteria. If so, then
a lower contribution of RNA to overall P would be observed.
However, the relatively low value we observed for human tissues is
likely to be realistic, as the contribution of RNA to biomass P is
predicted to decline from humans to small invertebrates because
growth rate and overall metabolic proliferation also decline with
increasing body size [13].
Despite these issues, averaged total P content and RNA content
for malignant or normal tissues for the four organ types showed
a strong and significant positive relationship (p,0.001, r
2=0.72).
In total, these results indicate that tumor development in lung and
colon involves shifts of biochemical allocations, including both
RNA and DNA, resulting in more than a two-fold increase in the
mass-specific demand for phosphorus. We note that this increase is
likely an underestimate of the elevated P demands of transformed
cells, as the biopsy samples of tumor tissues likely involve an
undetermined mixture of both transformed and normal cells along
with acellular stromal matrix.
An obvious question emerging from our data is why tumor
tissues are enriched in P and nucleic acids in colon and lung but
not in liver and kidney. Long-standing theory of r/K-selection
from evolutionary ecology [14] provides a hypothesis. In r/K
selection theory, environmental conditions such as disturbance or
high rates of predation are thought to favor individuals with rapid
development rate and high fecundity, with a general trade-off in
that they are weak competitors when resources become limiting
[14]. This is ‘‘r selection.’’ (‘‘r’’ refers to the maximum rate of
population increase in population dynamic equations.) In contrast,
‘‘K selection’’ involves a scenario in which stable conditions result
in an environment in which resources may often be insufficient to
support maximal growth, thus favoring reduced mortality rates
and improved competitive abilities. (‘‘K’’ refers to the carrying
capacity parameter in population equations.)
Applying these ideas to our data, we hypothesize that, because
external epithelial tissues experience routinely unstable conditions
imposing high levels of external mortality (for lung, especially under
Figure 4. Scatter plots of patient-specific data for paired observations of P content (% of dry mass) for malignant (y-axis) and normal (x-axis)
tissues in the four organs studied. The dotted line indicates the 1:1 relationship. A data point lying above the line indicates that P content is
elevated in malignant tissues, relative to normal, in that patient.
doi:10.1371/journal.pone.0001028.g004
Tumor Stoichiometry
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lung and colon may reflect the outcome of long-term selection
favoring cellular transformations increasing cell division rate (‘‘r-
selected’’). In contrast, more stable local conditions in liver and
kidney may instead predominantly favor transformed cells that have
acquired lower rates of cellular mortality, such as reduced apoptosis
(‘‘K-selected’’). Under the GRH, the r-strategy requires a particular
biochemical allocation affecting biomass P content, but a K-strategy
does not. These ideas can be tested by characterizing the particular
genetic transformations that predominate in P-rich tumors vs. those
that predominate in low-P tumors. Our hypothesis predicts that P-
rich tumors should be dominated by cells with genetic lesions
interfering with appropriate down-regulation of ribosome pro-
duction or other cell-cycle checks while low-P tumors should be
dominated by cells with mutations leading to inappropriately low
rates of apoptosis or senescence.
Existing data hint at the potential validity of such a framework.
For example, it is known that over-expression of c-myc protein
leads to increased cellular proliferation via amplified rates of
ribosome biogenesis [15] and that myc is over-expressed in 70% of
colon cancers [16], consistent with the P-rich signature that we
document (Figure 1). Thus, cellular transformation via myc
represents a possible pathway to a P-rich ‘‘r-selected’’ tumor.
We propose a similar scenario for tumorigenesis via mutations
involving retinoblastoma protein, which is involved in regulation
of RNA polymerases I and III [17]. With respect to development
of ‘‘K-selected’’ tumors, possible genetic mechanisms may include
loss-of-function mutations in Fas-mediated [18] or COX-mediated
[19] signaling pathways to apoptosis. Indeed, Fas-mediated
apoptosis provides an evolutionary mechanism by which tumor
cells evade apoptosis signals via DcR3, a ‘‘decoy receptor’’ for the
Fas protein ligand, FasL. DcR3 efficiently binds FasL and
neutralizes its effectiveness as an effector molecule for cytotoxic
T and NK cells. DcR3 has been shown to be significantly
amplified in 50% of primary lung and colon tumors [20]. This
evidence of selection for reduced apoptotic loss (a pathway
consistent with K-selection, not r-selection) in lung and colon
cancer is inconsistent with our argument that P-rich lung and
colon tumors are the products of r selection. However, since many
tumor suppressor genes and oncogenes have multiple direct and
indirect effects on both cellular replication and cellular death (p53
being a prominent example, [21]), it is likely that tumor
development reflects the simultaneous operation of multiple
mechanisms. It is also important to recognize that r/K selection
theory proposes not a qualitative categorization of evolutionary
outcomes but instead proposes a continuous gradient of relative
contributions of r-selected and K-selected traits for any given
species. This likely also holds for tumors. The challenge, amid the
Figure 5. Scatter plots of patient-specific data for paired observations of RNA content (% of dry mass) for malignant (y-axis) and normal (x-axis)
tissues in the four organs studied. The dotted line indicates the 1:1 relationship. A data point lying above the line indicates that RNA content is
elevated in malignant tissues, relative to normal, in that patient.
doi:10.1371/journal.pone.0001028.g005
Tumor Stoichiometry
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identify which alternative pathways (replication acceleration vs.
mortality reduction) predominate under which conditions and
why. Emerging genomic and transcriptomic approaches hold
considerable promise for functionally categorizing different tumors
along an r/K continuum. For example, genomic analyses of high-
P tumors may reveal that they are dominated by cells containing
mutations associated primarily with cell-cycle regulation or
ribosome biogenesis while low-P tumors may be dominated by
cells harboring genetic changes resulting in reduced rates of
apoptosis or cellular senescence.
Ecological studies have shown that P-rich organisms are
generally more susceptible to P-limited growth due to insufficient
supplies of P from the external environment or diet [5]. Whether
neoplasms with amplified P content (such as the ,2-fold increase
of P-content in colon and lung tumors) also experience P-limited
growth remains to be tested. However, existing clinical data do
suggest that the elevated P demands of proliferating tumors can
have body-wide physiological effects. For example, oncological
hypophosphatemia has been hypothesized in some cases to reflect
transfer of serum PO4 into replicating tumor cells [22]. Tumor-
induced osteomalacia [23], a relatively rare condition in which
tumor cells release (newly identified) phosphatonins that lead to
elevated renal PO4 loss and mobilization of PO4 from bones, is
another intriguing example of a connection between tumor
development and P homeostasis. While preliminary, our findings
indicate that, for at least some tumors, the requirements for the
key nutrient element phosphorus differ substantially from those of
normal tissues. Future studies are needed to evaluate whether the
amplification of P content in tumor tissues that we document has
physiological significance and whether it may provide additional
avenues for therapy. Additional work further characterizing the
stoichiometric signature of tumor tissues and examining the
dynamical consequences of observed differences for tumor
progression and for selection among clonal lineages is needed as
well.
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